ADD ANYTHING HERE OR JUST REMOVE IT…
Wrong menu selected
Acarix Acarix
  • Product

    Background

    • What is Coronary Artery Disease (CAD)?
    • Diagnosing CAD

    About the product

    • The CADScor® System
    • How does it work
  • Resources

    Testimonials

    • HCP stories
    • Patient stories

    References

    • Clinical Studies
    • Questionnaire
    • Downloads (US)
    • Downloads (EU)
    • Education

    Support

    • Training
    • FAQ
    • Reimbursement

    Physician Locator

    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Rights Issue/Warrant Program
    • Previous Rights Issue
    • Investor Presentations
  • Company

    Who we are

    • About Acarix
    • leadership
    • Join the team

    Get in touch

    • Contact us
    • Investigator Initiated Study
  • News
    • Press
    • Events
    • Social Media
Account
Search
Book a Demo
Acarix Acarix
Book a demo
Menu
author-avatar acarix
Interim, IR, Listing Regulation, News, Q2, Regulatory, Report, Swedish
November 18, 2024
31 Aug 2023

Acarix AB (publ) publicerar delårsrapport, april – juni 2023

Dragkraft på den amerikanska marknaden återspeglar övergången till en ny kommersiell modellUnder 2022 påb&...
Continue reading
author-avatar acarix
Corporate Information, English, General meeting, IR, Listing Regulation, News, Regulatory, Report of the AGM
November 18, 2024
09 Jun 2023

Announcement from Acarix’s extra general meeting

The extra general meeting of Acarix AB (the "Company") was held today on 9 June 2023 and the following resolutions were passed by the m...
Continue reading
author-avatar acarix
Corporate Information, General meeting, IR, Listing Regulation, News, Regulatory, Report of the AGM, Swedish
November 18, 2024
09 Jun 2023

Kommuniké från extra bolagsstämma i Acarix

Extra bolagsstämma i Acarix AB ("Bolaget") hölls idag den 9 juni 2023 varvid aktieägarna fattade följande beslut.Be...
Continue reading
author-avatar acarix
Corporate Information, English, General meeting, IR, Listing Regulation, News, Notice, Regulatory
November 18, 2024
22 May 2023

Notice of Extra General Meeting in Acarix AB

The shareholders of Acarix AB, reg. no. 559009-0667, (the "Company"), are hereby invited to the extra general meeting to be held on Fri...
Continue reading
author-avatar acarix
Corporate Information, General meeting, IR, Listing Regulation, News, Notice, Regulatory, Swedish
November 18, 2024
22 May 2023

Kallelse till extra bolagsstämma i Acarix AB

Aktieägarna i Acarix AB, org.nr 559009-0667, ("Bolaget") kallas härmed till extra bolagsstämma fredagen den 9 juni 2023 ...
Continue reading
author-avatar acarix
Corporate Action, English, IR, Issuance, Listing Regulation, News, Regulatory, Shares
November 18, 2024
22 May 2023

Acarix raises approximately SEK 22 million through exercise of warrants and resolves on a directed share issue

In December 2022, Acarix AB (publ) (“Acarix” or the “Company”) carried out a rights issue of shares and warrant...
Continue reading
author-avatar acarix
Corporate Action, IR, Issuance, Listing Regulation, News, Regulatory, Shares, Swedish
November 18, 2024
22 May 2023

Acarix tillförs cirka 22 MSEK genom utnyttjandet av teckningsoptioner och beslutar om riktad nyemission

Acarix AB (publ) (“Acarix” eller “Bolaget”) genomförde under december 2022 en företrädesemission...
Continue reading
author-avatar acarix
Corporate Information, English, General meeting, IR, Listing Regulation, News, Regulatory, Report of the AGM
November 18, 2024
11 May 2023

Announcement from Acarix’s annual general meeting

The annual general meeting 2023 ("AGM") of Acarix AB ("Acarix" or the "Company") was held today on 11 May 2023 in Stockholm and the fol...
Continue reading
author-avatar acarix
Corporate Information, General meeting, IR, Listing Regulation, News, Regulatory, Report of the AGM, Swedish
November 18, 2024
11 May 2023

Kommuniké från årsstämman i Acarix

Årsstämman 2023 i Acarix AB ("Acarix" eller "Bolaget") hölls idag den 11 maj 2023 i Stockholm varvid aktieägarna f...
Continue reading
author-avatar acarix
English, Interim, IR, Listing Regulation, News, Q1, Regulatory, Report
November 18, 2024
11 May 2023

Acarix AB (publ) publishes Interim Report, January – March 2023

2023 is off to a good startIn the first quarter of 2023 our strategy delivered important results with a breakthrough order from the lar...
Continue reading
author-avatar acarix
Interim, IR, Listing Regulation, News, Q1, Regulatory, Report, Swedish
November 18, 2024
11 May 2023

Acarix AB (publ) publicerar delårsrapport, januari – mars 2023

2023 har börjat braUnder första kvartalet 2023 levererade vi viktiga delresultat med en genombrottsorder från den st&ou...
Continue reading
author-avatar acarix
Corporate Information, English, IR, Listing Regulation, News, Other Corporate Information, Regulatory
November 18, 2024
02 May 2023

The exercise period for Acarix warrants of series 2022:U begins today

In December 2022, Acarix AB (publ) (“Acarix” or the “Company”) carried out a rights issue of shares and warrant...
Continue reading
  • «
  • ‹
  • 4
  • 5
  • 6
  • 7
  • 8
  • ›
  • »
Acarix AB
Jungmansgatan 12
211 19 Malmö
SE
[email protected]

Product

Background

  • What is Coronary Artery Disease (CAD)?
  • Diagnosing CAD

About the product

  • The CADScor® System
  • How does it work

Resources

Testimonials

  • HCP stories
  • Patient stories

Support

  • Training
  • FAQ

References

  • Clinical Studies
  • Downloads (US)
  • Downloads (EU)

Investors

  • Corporate Governance
  • General Meetings
  • Financial Reports and Calendar
  • The Acarix Share
  • Rights Issue
  • Investor Presentations

Company

Who we are

  • About Acarix
  • Management
  • Join the team

Get in touch

  • Contact us
  • LinkedIn
  • Twitter

News

  • Press
  • Events
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy

Acarix, 2025. All rights reserved V5

  • Products
    • Background
    • What is Coronary Artery Disease
    • Diagnosing CAD
    • About the product
    • The Cadscor System
    • How Does it Work
  • Resources
    • Testimonial
    • HCP Stories
    • Patients Stories
    • References
    • Clinical Studies
    • Downloads (US)
    • Downloads (EU)
    • Support
    • Training
    • Faq
    • Reimbursement
    • Physician Locator
    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Right Issue
    • Previous Rights Issue
    • Investor Presentations
  • Company
    • Who we are
    • About Acarix
    • Leadership
    • Join The Team
    • Get in touch
    • Contact Us
    • Investigator Initiated Study
  • News
    • News
    • Press
    • Events
    • Socialmedia
Start typing to see products you are looking for.